The intricacies of neurotrophic factor therapy for retinal ganglion cell rescue in glaucoma: a case for gene therapy.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27482199)

Published in Neural Regen Res on June 01, 2016

Authors

Marianna Foldvari1, Ding Wen Chen1

Author Affiliations

1: School of Pharmacy, Waterloo Institute of Nanotechnology and Center for Bioengineering and Biotechnology, University of Waterloo, Waterloo, ON, Canada.

Articles cited by this

A forensic path to RGC-5 cell line identification: lessons learned. Invest Ophthalmol Vis Sci (2013) 3.31

Gene therapy with brain-derived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma model. Invest Ophthalmol Vis Sci (2003) 1.83

The types of retinal ganglion cells: current status and implications for neuronal classification. Annu Rev Neurosci (2015) 1.70

Prolonged delivery of brain-derived neurotrophic factor by adenovirus-infected Müller cells temporarily rescues injured retinal ganglion cells. Proc Natl Acad Sci U S A (1998) 1.60

Effects of optic nerve injury, glaucoma, and neuroprotection on the survival, structure, and function of ganglion cells in the mammalian retina. J Physiol (2008) 1.38

Differential progression of structural and functional alterations in distinct retinal ganglion cell types in a mouse model of glaucoma. J Neurosci (2013) 1.31

Subtype-specific regeneration of retinal ganglion cells following axotomy: effects of osteopontin and mTOR signaling. Neuron (2015) 1.23

Neurotrophin roles in retinal ganglion cell survival: lessons from rat glaucoma models. Exp Eye Res (2009) 1.08

Combined application of BDNF to the eye and brain enhances ganglion cell survival and function in the cat after optic nerve injury. Invest Ophthalmol Vis Sci (2009) 1.07

Biodistribution of rAAV vectors following intraocular administration: evidence for the presence and persistence of vector DNA in the optic nerve and in the brain. Mol Ther (2005) 1.07

Comparative analysis of DNA nanoparticles and AAVs for ocular gene delivery. PLoS One (2012) 0.96

Preclinical development and ocular biodistribution of gemini-DNA nanoparticles after intravitreal and topical administration: towards non-invasive glaucoma gene therapy. Nanomedicine (2014) 0.87

Neural stem cell-based intraocular administration of ciliary neurotrophic factor attenuates the loss of axotomized ganglion cells in adult mice. Invest Ophthalmol Vis Sci (2014) 0.85

Long-term rescue of rat retinal ganglion cells and visual function by AAV-mediated BDNF expression after acute elevation of intraocular pressure. Invest Ophthalmol Vis Sci (2012) 0.83

Challenges in neuroprotective nanomedicine development: progress towards noninvasive gene therapy of glaucoma. Nanomedicine (Lond) (2012) 0.81

The role of lamina cribrosa cells in optic nerve head fibrosis in glaucoma. Exp Eye Res (2016) 0.80

Intranasal gene delivery for treating Parkinson's disease: overcoming the blood-brain barrier. Expert Opin Drug Deliv (2015) 0.79